Loading...
Loading...
Among the 7 tracked institutional investors we monitor, URGN (UROGEN PHARMA LTD) is held with a combined value of $94.22M across 5,107,094 shares. The largest holder is BlackRock, Inc. with a position worth $51.16M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$94.22M
Total Shares Held
5,107,094
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $51.16M | 0.00% | +9.4% |
| 2 | STATE STREET CORP | $15.72M | 0.00% | +8.3% |
| 3 | VANGUARD GROUP INC | $10.30M | 0.00% | New |
| 4 | MILLENNIUM MANAGEMENT LLC | $6.67M | 0.00% | -40.1% |
| 5 | CITADEL ADVISORS LLC | $5.69M | 0.00% | -61.5% |
| 6 | FMR LLC | $2.61M | 0.00% | +17.3% |
| 7 | ARK Investment Management LLC | $2.08M | 0.02% | -4.9% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of URGN with a position worth $51.16M, representing 0.00% of their portfolio. In total, 7 institutional investors hold URGN with a combined value of $94.22M.
In the most recent quarter, 1 fund opened a new position in URGN. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $94.22M worth of URGN stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $51.16M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For URGN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their URGN positions.